STERIS plc $STE Stock: One Way Holdings LLC Lowers Stake

One Way Holdings LLC cut its stake in shares of STERIS plc (NYSE:STE) by 93.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,499 shares of the medical equipment provider’s stock after selling 78,347 shares during the quarter. One Way Holdings LLC’s holdings in STERIS were worth $1,155,000 at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of STE. Wellington Management Group LLP increased its position in STERIS by 21.9% in the 2nd quarter. Wellington Management Group LLP now owns 3,502,897 shares of the medical equipment provider’s stock valued at $737,605,000 after buying an additional 629,532 shares in the last quarter. Janus Henderson Group PLC raised its stake in STERIS by 25.7% during the 1st quarter. Janus Henderson Group PLC now owns 1,863,139 shares of the medical equipment provider’s stock worth $411,995,000 after buying an additional 380,504 shares during the period. Amundi boosted its holdings in STERIS by 43.2% in the first quarter. Amundi now owns 771,092 shares of the medical equipment provider’s stock worth $170,512,000 after acquiring an additional 232,520 shares in the last quarter. SEB Asset Management AB bought a new stake in shares of STERIS during the first quarter valued at approximately $30,660,000. Finally, Hsbc Holdings PLC increased its holdings in shares of STERIS by 352.5% during the first quarter. Hsbc Holdings PLC now owns 176,320 shares of the medical equipment provider’s stock valued at $38,958,000 after acquiring an additional 137,355 shares in the last quarter. 94.69% of the stock is currently owned by institutional investors and hedge funds.

STERIS Stock Down 0.0%

STE opened at $227.07 on Monday. STERIS plc has a twelve month low of $195.14 and a twelve month high of $269.44. The company’s 50-day moving average price is $219.81 and its two-hundred day moving average price is $225.20. The stock has a market cap of $22.14 billion, a price-to-earnings ratio of 27.76 and a beta of 0.86. The company has a quick ratio of 1.35, a current ratio of 1.91 and a debt-to-equity ratio of 0.23.

STERIS (NYSE:STE) last issued its quarterly earnings results on Wednesday, August 5th. The medical equipment provider reported $2.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.49 by $0.10. The company had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.49 billion. STERIS had a net margin of 13.34% and a return on equity of 14.34%. STERIS’s quarterly revenue was up 7.3% compared to the same quarter last year. During the same quarter last year, the business posted $2.34 EPS. STERIS has set its FY 2027 guidance at 11.000-11.300 EPS. As a group, equities analysts expect that STERIS plc will post 11.17 earnings per share for the current year.

STERIS Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 17th. Investors of record on Tuesday, November 17th will be issued a $0.69 dividend. The ex-dividend date of this dividend is Tuesday, November 17th. This represents a $2.76 annualized dividend and a yield of 1.2%. STERIS’s dividend payout ratio (DPR) is 33.74%.

Insider Transactions at STERIS

In other STERIS news, Director Mohsen Sohi sold 4,058 shares of the stock in a transaction dated Wednesday, August 12th. The shares were sold at an average price of $235.78, for a total transaction of $956,795.24. Following the completion of the transaction, the director owned 24,305 shares in the company, valued at $5,730,632.90. This trade represents a 14.31% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 1.12% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the stock. Wall Street Zen lowered shares of STERIS from a “strong-buy” rating to a “buy” rating in a report on Sunday, October 11th. Piper Sandler reissued an “overweight” rating and issued a $275.00 price objective (up from $270.00) on shares of STERIS in a research note on Friday, August 7th. UBS Group cut their target price on STERIS from $275.00 to $270.00 and set a “buy” rating on the stock in a research report on Friday, August 7th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of STERIS in a report on Monday, August 24th. Three investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $271.33.

STERIS Profile

STERIS plc (NYSE: STE) provides products and services designed to support infection prevention, procedural care and the safe manufacture of healthcare and life sciences products. Its offerings include surgical equipment and operating-room solutions, sterilization and decontamination systems, endoscopy products, cleaning and disinfection technologies, and related consumable products.

The company also provides outsourced sterilization and laboratory services through its Applied Sterilization Technologies business.